The Systemic Immune Network in Recent Onset Type 1 Diabetes: Central Role of Interleukin-1 Receptor Antagonist (DIATOR Trial)

BACKGROUND: The hypothesis was tested that the systemic immune milieu in recent-onset type 1 diabetes is associated with residual beta cell function and other metabolic patient characteristics. METHODS AND FINDINGS: All patients (n = 89, 40% female) of the Diabetes and Atorvastatin (DIATOR) Trial we...

Descripción completa

Detalles Bibliográficos
Autores principales: Kolb, Hubert, Lückemeyer, Kathrin, Heise, Tim, Herder, Christian, Schloot, Nanette C., Koenig, Wolfgang, Heinemann, Lutz, Martin, Stephan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753272/
https://www.ncbi.nlm.nih.gov/pubmed/23991111
http://dx.doi.org/10.1371/journal.pone.0072440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753272/
https://www.ncbi.nlm.nih.gov/pubmed/23991111
http://dx.doi.org/10.1371/journal.pone.0072440

Ejemplares similares